The Worldwide IVD Market, 2019-2024

    NEXT STORY
    Oasmia’s rights issue has been oversubscribed
    PREV STORY
    Half-year report
    Subscribe to PM360
    Follow Us

    Experts on Call

    Get in touch with PM360 Experts On Call
    NEXT STORY
    Oasmia’s rights issue has been oversubscribed
    PREV STORY
    Half-year report
    Subscribe to PM360
    Follow Us

    Experts on Call

    Get in touch with PM360 Experts On Call

    Ads

    You May Also Like

    Putting new tools in the hands of leading Canadian scientists

    WINNIPEG, Manitoba, Oct. 12, 2017 (GLOBE NEWSWIRE) -- Imagine a nano-sized anti-cancer drug that ...

    author_avatar
    NASDAQ Market News

    Roche’s Gazyva (obinutuzumab), in combination with standard of care, more than doubles the percentage of lupus nephritis patients achieving complete renal response, compared to standard of care alone

    author_avatar
    NASDAQ Market News

    Progressive Care Installs New TCGRx Pouch Packaging System in Miami

    Leading Florida-Based Healthcare Services and Technology Company Continues Expansion of Robot Pharmacy Machinery FleetMIAMI, ...

    author_avatar
    NASDAQ Market News